These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3121524)

  • 1. Distribution and survival of passively transferred lymphoblasts in normal and tumor-bearing mice.
    Normann SJ; Cornelius J
    Int J Cancer; 1988 Jan; 41(1):143-9. PubMed ID: 3121524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent depression of tumor macrophage infiltration and systemic inflammation by progressive cancer growth.
    Normann SJ; Cornelius J
    Cancer Res; 1978 Oct; 38(10):3453-9. PubMed ID: 99232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive immunotherapy of microscopic and advanced visceral metastases with in vitro sensitized lymphoid cells from mice bearing progressive tumors.
    Chou T; Bertera S; Chang AE; Shu S
    J Immunol; 1988 Sep; 141(5):1775-81. PubMed ID: 3261761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell threshold required for suppression of macrophage inflammation.
    Normann SJ
    J Natl Cancer Inst; 1978 May; 60(5):1091-6. PubMed ID: 417187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Humoral mechanisms of the membrano-toxic effects of mastocytoma P815 and leukemia EL4 cells].
    Medvedev AE; Fuks BB
    Biull Eksp Biol Med; 1989 Aug; 108(8):194-6. PubMed ID: 2508789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion.
    Suzuki Y; Adachi Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Ikehara S
    Stem Cells; 2005 Mar; 23(3):365-70. PubMed ID: 15749931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage infiltration in tumors and tumor-surrounding tissue: influence of serotonin and sensitized lymphocytes.
    Los G; De Weger RA; Van den Berg DT; Sakkers R; Den Otter W
    Cancer Immunol Immunother; 1988; 26(2):145-52. PubMed ID: 3282654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of tumor rejection by autologous anti-idiotypic immunity.
    Flood PM; Kripke ML; Rowley DA; Schreiber H
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2209-13. PubMed ID: 6966405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spleen white pulp morphology as an indicator of the immunological state in DBA/2 mice bearing mastocytoma.
    Syrjänen KJ
    Exp Pathol (Jena); 1980; 18(4):223-31. PubMed ID: 6772464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
    Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
    J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.
    Dye ES; North RJ
    J Exp Med; 1981 Oct; 154(4):1033-42. PubMed ID: 6457075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.
    Mills CD; North RJ
    J Exp Med; 1983 May; 157(5):1448-60. PubMed ID: 6189937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
    Reichert CM; Rosenstein M; Von Glatz J; Hsu SM; Rosenberg SA
    Lab Invest; 1985 Mar; 52(3):304-13. PubMed ID: 3974201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The specificity of concomitant tumor immunity at large tumor volumes.
    Deckers PJ; Pardridge DH; Wang BS; Mannick JA
    Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Self-reactive" T cells. I. In vivo reaction of T cells to transferred polyclonally activated syngeneic and autologous lymphoblasts.
    Reimann J; Diamantstein T
    Immunobiology; 1980 Dec; 157(4-5):437-49. PubMed ID: 6969688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of normal syngeneic lymphoid cells on growth of methyl cholanthrene induced fibrosarcomas in mice.
    Gautam S; Aikat BK
    Indian J Med Res; 1976 Mar; 64(3):482-93. PubMed ID: 965049
    [No Abstract]   [Full Text] [Related]  

  • 19. Motility of splenic cells from normal and fibrosarcoma-bearing mice in agarose assay.
    Aroskar VS; Chaubal KA
    Tumori; 1986 Jun; 72(3):225-9. PubMed ID: 3739002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.
    Maas RA; Roest PA; Becker MJ; Weimar IS; Dullens HF; Den Otter W
    Immunobiology; 1992 Nov; 186(3-4):214-29. PubMed ID: 1490728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.